1,266
Views
27
CrossRef citations to date
0
Altmetric
Original Articles

Delivery of plasmid encoding interleukin-12 gene into hepatocytes by conjugated polyethylenimine-based nanoparticles

, , , , , & show all
Pages 1036-1044 | Received 03 Feb 2016, Accepted 13 Jun 2016, Published online: 30 Jun 2016

References

  • Alvarez RD, Sill MW, Davidson SA, Muller CY, Bender DP, De Bernardo RL, et al. 2014. A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study. Gynecol Oncol. 133:433–438.
  • Boussif O, Lezoualc’h F, Zanta MA, Mergny MD, Scherman D Demeneix B, et al. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA. 92:7297–7301.
  • Choi KJ, Zhang SN, Choi IK, Kim JS, Yun CO. 2012. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF. Gene Ther. 19:711–723.
  • Cohen J. 1995. IL-12 deaths: explanation and a puzzle. Science. 270:908.
  • Dass C, Hallaj-Nezhadi S, Lotfipour F. 2010. Nanoparticle-mediated interleukin-12 cancer gene therapy. J Pharm Pharm Sci. 13:472–485.
  • Dehshahri A, Oskuee RK, Ramezani M. 2012. Plasmid DNA delivery into hepatocytes using a multifunctional nanocarrier based on sugar-conjugated polyethylenimine. Gene Ther Mol Biol. 14:62–71.
  • Dehshahri A, Oskuee RK, Shier WT, Hatefi A, Ramezani M. 2009. Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine. Biomaterials. 30:4187–4194.
  • Dehshahri A, Sadeghpour H. 2015. Surface decorations of poly(amidoamine) dendrimer by various pendant moieties for improved delivery of nucleic acid materials. Colloids Surf B Biointerfaces. 132:85–102.
  • Dehshahri A, Sadeghpour H, Oskuee RK, Fadaei M, Sabahi Z, Alhashemi SH, et al. 2014. Interleukin-12 plasmid DNA delivery using l-thyroxine-conjugated polyethylenimine nanocarriers. J Nanopart Res. 16:1–14.
  • Doody AM, Korley JN, Dang KP, Zawaneh P, Putnam D. 2006. Characterizing the structure/function parameter space of hydrocarbon-conjugated branched polyethylenimine for DNA delivery in vitro. J Control Release. 116:227–237.
  • Ebrahiminezhad A, Ghasemi Y, Rasoul-Amini S, Barar J, Davaran S. 2013. Preparation of novel magnetic fluorescent nanoparticles using amino acids. Colloids Surf B Biointerfaces. 102:534–539.
  • Forrest ML, Meister GE, Koerber J, Pack DW. 2004. Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharm Res. 21:365–371.
  • Gabrielson NP, Pack DW. 2006. Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules. 7:2427–2435.
  • Hanci D, Sahin E, Muluk N, Cingi C. 2016. Immunotherapy in all aspects. Eur Arch Otorhinolaryngol. 273:1347–1355.
  • Hashida M, Mahato RI, Kawabata K, Miyao T, Nishikawa M, Takakura Y. 1996. Pharmacokinetics and targeted delivery of proteins and genes. J Control Release. 41:91–97.
  • Kafshdooz T, Kafshdooz L, Akbarzadeh A, Hanifehpour Y, Joo SW. 2016. Applications of nanoparticle systems in gene delivery and gene therapy. Artif Cells Nanomed Biotechnol. 44:581–587.
  • Kim J, Wilson DR, Zamboni CG, Green JJ. 2015. Targeted polymeric nanoparticles for cancer gene therapy. J Drug Target. 23:627–641.
  • Lee C-H, Ni Y-H, Chen C-C, Chou C-K, Chang F-H. 2003. Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells. Biochim Biophys Acta. 1611:55–62.
  • Li L, He Z-Y, Wei X-W, Gao G-P, Wei Y-Q. 2015. Challenges in CRISPR/CAS9 delivery: potential roles of nonviral vectors. Hum Gene Ther. 26:452–462.
  • Malakooty Poor E, Baghaban Eslaminejad M, Gheibi N, Bagheri FA, tyabi F. 2014. Chitosan–pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 42:376–384.
  • Mao H-Q, Roy K, Troung Le VL, Janes KA, Lin KY, Wang Y, et al. 2001. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 70:399–421.
  • Mao S, Neu M, Germershaus O, Merkel O, Sitterberg J, Bakowsky U, et al. 2006. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly (ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjug Chem. 17:1209–1218.
  • Nezafat N, Sadraeian M, Rahbar MR, Khoshnoud MJ, Mohkam M, Gholami A, et al. 2015. Production of a novel multi-epitope peptide vaccine for cancer immunotherapy in TC-1 tumor-bearing mice. Biologicals. 43:11–17.
  • Nimesh S, Aggarwal A, Kumar P, Singh Y, Gupta K, Chandra R. 2007. Influence of acyl chain length on transfection mediated by acylated PEI nanoparticles. Int J Pharm. 337:265–274.
  • Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E. 1998. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 5:1425–1433.
  • Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, et al. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med. 181:901–914.
  • Oskuee RK, Dehshahri A, Shier W, Ramezani M. 2008. Modified polyethylenimine: self assemble nanoparticle forming polymer for pDNA delivery. Iran J Basic Med Sci. 11:33–40.
  • Oskuee RK, Dehshahri A, Shier W T., Ramezani M. 2009. Alkylcarboxylate grafting to polyethylenimine: a simple approach to producing a DNA nanocarrier with low toxicity. J Gene Med. 11:921–932.
  • Parhiz H, Shier WT, Ramezani M. 2013. From rationally designed polymeric and peptidic systems to sophisticated gene delivery nano-vectors. Int J Pharm. 457:237–259.
  • Paul A, Eun C-J, Song JM. 2014. Cytotoxicity mechanism of non-viral carriers polyethylenimine and poly-l-lysine using real time high-content cellular assay. Polymer. 55:5178–5188.
  • Petros RA, DeSimone JM. 2010. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 9:615–627.
  • Quezada A, French M, Perrard J, Durland R, Coleman M, Larson J, et al. 2004. Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models. J. Pharm. Pharmacol. 56:177–185.
  • Radford KJ, Tullett KM, Lahoud MH. 2014. Dendritic cells and cancer immunotherapy. Curr Opin Immunol. 27:26–32.
  • Rezvani Z, Rahimizadeh M, Eshghi H, Dehshahri A, Ramezani M. 2013. The effect of cationic charge density change on transfection efficiency of polyethylenimine. Iran J Basic Med Sci. 16:150–156.
  • Sabahi Z, Samani SM, Dehshahri A. 2015. Conjugation of poly (amidoamine) dendrimers with various acrylates for improved delivery of plasmid encoding interleukin-12 gene. J Biomater Appl. 29:941–953.
  • Thomas M, Klibanov AM. 2002. Enhancing polyethylenimine’s delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA. 99:14640–14645.
  • Wang DA, Narang AS, Kotb M, Gaber AO, Miller DD, Kim SW, et al. 2002. Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery. Biomacromolecules. 3:1197–1207.
  • Watford WT, Moriguchi M, Morinobu A, O’Shea JJ. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14:361–368.
  • Zhang Y, Wei H, Xu L, Yan G, Ma C, Yu M, et al. 2016. Preparation and evaluation of a non-viral gene vector for SiRNA: multifunctional envelope-type nano device. Artif Cells Nanomed Biotechnol. 44:1259–1265.
  • Zhao L, Wu J, Zhou H, Yuan A, Zhang X, Xu F, et al. 2011. Local gene delivery for cancer therapy. Curr Gene Ther. 11:423–432.
  • Zintchenko A, Philipp A, Dehshahri A, Wagner E. 2008. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem. 19:1448–1455.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.